Aptamer-mediated transcriptional gene silencing of Foxp3 inhibits regulatory T cells and potentiates antitumor response-Reference-Cited by-同舟云学术

Aptamer-mediated transcriptional gene silencing of Foxp3 inhibits regulatory T cells and potentiates antitumor response

Published:2021-09 Issue: Volume:25 Page:143-151
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Manrique-Rincón Andrea J.,Ruas Luciana P.,Fogagnolo Carolinne T.,Brenneman Randall J.,Berezhnoy Alexey,Castelucci Bianca,Consonni Sílvio R.,Gilboa Eli,Bajgelman Marcio C.

Funder

Fundação de Amparo à Pesquisa do Estado de São Paulo

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference59 articles.

1. Foxp3+ regulatory T cells: differentiation, specification, subphenotypes;Feuerer;Nat. Immunol.,2009

2. Regulatory T cells: mechanisms of differentiation and function;Josefowicz;Annu. Rev. Immunol.,2012

3. Turning the Tide Against Regulatory T Cells;Han;Front. Oncol.,2019

4. Natural regulatory T cells and de novo-induced regulatory T cells contribute independently to tumor-specific tolerance;Zhou;J. Immunol.,2007

5. Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis;Shang;Sci. Rep.,2015

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infiltrating treg reprogramming in the tumor immune microenvironment and its optimization for immunotherapy;Biomarker Research;2024-09-04

2. Efficacy of novel allogeneic cancer cells vaccine to treat colorectal cancer;Frontiers in Oncology;2024-07-24

3. Many Faces of Regulatory T Cells: Heterogeneity or Plasticity?;Cells;2024-06-01

4. Drug conjugates for targeting regulatory T cells in the tumor microenvironment: guided missiles for cancer treatment;Experimental & Molecular Medicine;2023-09-01

5. Breast cancer tumor microenvironment affects Treg/IL-17-producing Treg/Th17 cell axis: Molecular and therapeutic perspectives;Molecular Therapy - Oncolytics;2023-03